Syndax Pharmaceuticals, Inc.SNDXNASDAQ
Loading
Research and development spending
3Y CAGR
+29.7%/yr
vs +18.5%/yr prior
5Y CAGR
+38.7%/yr
Recent deceleration
Acceleration
+11.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.1x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $258.78M | +7.1% |
| 2024 | $241.65M | +48.2% |
| 2023 | $163.03M | +37.6% |
| 2022 | $118.50M | +34.3% |
| 2021 | $88.25M | +75.0% |
| 2020 | $50.44M | +17.3% |
| 2019 | $42.99M | -28.5% |
| 2018 | $60.11M | +24.7% |
| 2017 | $48.20M | +52.2% |
| 2016 | $31.66M | - |